-transparent.png){kind=logo}
Three Hodgkin's disease-derived cell lines were analysed for the organization of immunoglobulin and T cell receptor genes, for the expression of the interleukin 2 (IL-2) receptor gene, and for the cellular oncogene c-myc. All three cell lines have characteristic genotypic markers of lymphoid cells and can be classified as immature lymphoid cells with respect to the incomplete expression of their antigen receptor genes. This immature genotype is in contrast to the expression of activation antigens Ki-1 (CD 30), IL-2 receptor (CD 25), and HLA-DR. The results obtained are in agreement with studies obtained from primary Hodgkin's lymphomas, which are activated by as yet unknown mechanisms.
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
April 1982,
Cancer treatment reports,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
March 1992,
Human cell,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
September 1987,
Leukemia,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
June 1988,
Leukemia,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
May 2000,
British journal of haematology,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
January 1985,
Cancer surveys,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
January 1989,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
July 1988,
Leukemia,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
May 2003,
International journal of cancer,
H Tesch, and
M Jücker, and
M H Falk, and
G W Bornkamm, and
D B Jones, and
V Diehl
August 1978,
Cancer research,
